Clinical factors related to recurrence of anterior segment neovascularization after treatment including intravitreal bevacizumab.

[1]  R. Zarei,et al.  Surgical Outcomes of Intravitreal Bevacizumab and Guarded Filtration Surgery in Neovascular Glaucoma , 2010, Journal of glaucoma.

[2]  S. Ohkubo,et al.  Beneficial effects of preoperative intravitreal bevacizumab on trabeculectomy outcomes in neovascular glaucoma , 2010, Acta ophthalmologica.

[3]  P. Szurman,et al.  Bevacizumab as adjuvant for neovascular glaucoma , 2010, Acta ophthalmologica.

[4]  Xiaoxin Li,et al.  Analysis of the clinical efficacy of intravitreal bevacizumab in the treatment of iris neovascularization caused by proliferative diabetic retinopathy , 2009, Acta ophthalmologica.

[5]  A. Rao,et al.  The Effect of Different Doses of Intracameral Bevacizumab on Surgical Outcomes of Trabeculectomy for Neovascular Glaucoma , 2009, European journal of ophthalmology.

[6]  S. Charles,et al.  Clinical outcomes of patients with anterior segment neovascularization treated with or without intraocular bevacizumab , 2009, Advances in therapy.

[7]  P. Rosenfeld,et al.  Outcomes of treatment of neovascular glaucoma with intravitreal bevacizumab , 2008, British Journal of Ophthalmology.

[8]  C. Costagliola,et al.  Intravitreal bevacizumab (Avastin) injection for neovascular glaucoma: a survey on 23 cases throughout 12-month follow-up. , 2008, British journal of clinical pharmacology.

[9]  N. Eter,et al.  Intraocular pharmacokinetics of bevacizumab after a single intravitreal injection in humans. , 2008, American journal of ophthalmology.

[10]  Y. Tano,et al.  Intravitreal bevacizumab to treat iris neovascularization and neovascular glaucoma secondary to ischemic retinal diseases in 41 consecutive cases. , 2008, Ophthalmology.

[11]  W. Tasman,et al.  COMBINATION INTRAVITREAL BEVACIZUMAB/PANRETINAL PHOTOCOAGULATION VERSUS PANRETINAL PHOTOCOAGULATION ALONE IN THE TREATMENT OF NEOVASCULAR GLAUCOMA , 2008, Retina.

[12]  S. Grover,et al.  Intracameral Avastin Dramatically Resolves Iris Neovascularization and Reverses Neovascular Glaucoma , 2008, European journal of ophthalmology.

[13]  S. Mohammadi,et al.  Bevacizumab-Augmented Retinal Laser Photocoagulation in Proliferative Diabetic Retinopathy: A Randomized Double-Masked Clinical Trial , 2008, European journal of ophthalmology.

[14]  S. Garg,et al.  Role of intravitreal bevacizumab in neovascular glaucoma. , 2007, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

[15]  R. Avery,et al.  Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy. , 2006, Ophthalmology.

[16]  R. Avery.  Regression of retinal and iris neovascularization after intravitreal bevacizumab (Avastin) treatment. , 2006, Retina.

[17]  Y. Ohnishi,et al.  Fluorescein gonioangiography in diabetic neovascularisation , 1994, Graefe's Archive for Clinical and Experimental Ophthalmology.

[18]  J. Sivak-Callcott,et al.  Evidence-based recommendations for the diagnosis and treatment of neovascular glaucoma. , 2001, Ophthalmology.

[19]  Sanborn Ge,et al.  Fundus-iris fluorescein angiography: evaluation of its use in the diagnosis of rubeosis iridis. , 1986 .

[20]  J. Walsh,et al.  A grading system for iris neovascularization. Prognostic implications for treatment. , 1981, Ophthalmology.